Literature DB >> 18021865

Management of herpes zoster and postherpetic neuralgia.

Stephen K Tyring1.   

Abstract

Patients with herpes zoster experience severe pain and potential lasting complications such as postherpetic neuralgia, ophthalmic disease/damage, and, rarely, skin complications (eg, infection of rash area). Treatment for acute zoster aims to accelerate healing, control pain, and, when possible, reduce the risk of complications. Early intervention with antivirals can accelerate rash healing, reduce rash severity, and reduce the risk of some complications. The addition of corticosteroids to antiviral medication may further alleviate short-term zoster pain, but is associated with an increased risk of serious adverse effects, especially among older adults. If a patient does develop postherpetic neuralgia, gabapentin, pregabalin, opioids, tricyclic antidepressants, lidocaine patch 5%, and capsaicin may all be considered as palliative treatments. For individuals with treatment-refractory postherpetic neuralgia, nonpharmacologic approaches may be considered and a pain-management specialist should be consulted. There is a need for more effective agents to treat herpes zoster and postherpetic neuralgia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18021865     DOI: 10.1016/j.jaad.2007.09.016

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  13 in total

1.  Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.

Authors:  Michael D Parkins; Shelly A McNeil; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

Review 2.  Auriculotherapy for pain management: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Gary N Asher; Daniel E Jonas; Remy R Coeytaux; Aimee C Reilly; Yen L Loh; Alison A Motsinger-Reif; Stacey J Winham
Journal:  J Altern Complement Med       Date:  2010-10       Impact factor: 2.579

3.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

Review 4.  Vaccination for quality of life: herpes-zoster vaccines.

Authors:  Pierre-Olivier Lang; Richard Aspinall
Journal:  Aging Clin Exp Res       Date:  2019-10-23       Impact factor: 3.636

5.  Efficacy of piroxicam patch compared to lidocaine patch for the treatment of postherpetic neuralgia.

Authors:  Jun Young Kim; Hyun Jung Lim; Weon Ju Lee; Seok-Jong Lee; Do Won Kim; Byung Soo Kim
Journal:  Ann Dermatol       Date:  2011-05-27       Impact factor: 1.444

6.  Neuroimmune-Glia Interactions in the Sensory Ganglia Account for the Development of Acute Herpetic Neuralgia.

Authors:  Jaqueline R Silva; Alexandre H Lopes; Jhimmy Talbot; Nerry T Cecilio; Mateus F Rossato; Rangel L Silva; Guilherme R Souza; Cassia R Silva; Guilherme Lucas; Benedito A Fonseca; Eurico Arruda; Jose C Alves-Filho; Fernando Q Cunha; Thiago M Cunha
Journal:  J Neurosci       Date:  2017-06-02       Impact factor: 6.167

Review 7.  Ocular herpes: the pathophysiology, management and treatment of herpetic eye diseases.

Authors:  Lucy Zhu; Hua Zhu
Journal:  Virol Sin       Date:  2014-12-15       Impact factor: 4.327

8.  Measuring the burden of herpes zoster and post herpetic neuralgia within primary care in rural Crete, Greece.

Authors:  Christos D Lionis; Constantine I Vardavas; Emmanouil K Symvoulakis; Maria G Papadakaki; Foteini S Anastasiou; Maria D Antonopoulou; Charalampos M Apostolakis; Stelios A Dimitrakopoulos; George I Fountakis; Ilias A Grammatikopoulos; John D Komninos; Dimitris K Kounalakis; Eva S Ladoukaki; Kornilia V Makri; Chrysa S Petraki; Nikos G Ploumis; Dimitra P Prokopiadou; Ioanna N Stefanaki; Nikos A Tsakountakis; Ioanna G Tsiligianni; Emmanouil N Tzortzis; Aggeliki A Vasilaki; Theodoros K Vasilopoulos; George E Vrentzos
Journal:  BMC Fam Pract       Date:  2011-12-06       Impact factor: 2.497

Review 9.  Antiepileptics for post-herpetic neuralgia in the elderly: current and future prospects.

Authors:  Gisèle Pickering
Journal:  Drugs Aging       Date:  2014-09       Impact factor: 4.271

10.  A Prospective Study of Herpes Zoster in Children.

Authors:  Bhumesh Kumar Katakam; Geeta Kiran; Udaya Kumar
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.